MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > Mir

<< Previous

Bullboard Posts

Next >>

Comment by conservative2on Feb 18, 2021 10:29am

92 Views

Post# 32595034

RE:Mir

I disagree with your assertion. Initially FDA rushed through the process of granting Emergency Use with poor checks and balances in place, which allowed poor tests to get on the market that did not perform. Their assessment process is now extremely rigorous. Those test that now make it through the accreditation proceess will test for covid with reliability and accuracy. MIRs test will be one of these tests. Patience is need. MIR will not be able to keep up with demand after approval is granted. Cheers Conservative2

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features